Abstract
In continuation of our studies on the genus Salvia fourteen alcoholic extracts of Salvia species were evaluated for their anticholinesterase activity. Among them, the most active extract at 200 μg/mL was found to be S. staminea with the inhibition of 55.17 and 79.75% against enzymes AChE and BChE, respectively. Pure isolated compounds from S. staminea were investigated for anticholinesterase activity at 200 μM, and the abietane diterpenoids ferruginol and taxodione were found to be the most promising isolates, which were then further investigated at five different concentrations, and both diterpenoids exhibited high activity, particularly against BChE enzyme with IC50 values of 7.73 and 10.52 μM, respectively. Salvia chrysophylla and Salvia poculata extracts also exhibited moderate anticholinesterase activity.
Keywords: Anticholinesterase, antioxidant, ferruginol, Salvia species, S. staminea, taxodione
The Natural Products Journal
Title:Investigation of Anticholinesterase Activity of a Series of Salvia Extracts and the Constituents of Salvia staminea
Volume: 3 Issue: 1
Author(s): Gulactı Topcu, Ufuk Kolak, Mehmet Ozturk, Mehmet Boga, Seda Damla Hatipoglu, Fatemeh Bahadori, Burcu Culhaoglu and Tuncay Dirmenci
Affiliation:
Keywords: Anticholinesterase, antioxidant, ferruginol, Salvia species, S. staminea, taxodione
Abstract: In continuation of our studies on the genus Salvia fourteen alcoholic extracts of Salvia species were evaluated for their anticholinesterase activity. Among them, the most active extract at 200 μg/mL was found to be S. staminea with the inhibition of 55.17 and 79.75% against enzymes AChE and BChE, respectively. Pure isolated compounds from S. staminea were investigated for anticholinesterase activity at 200 μM, and the abietane diterpenoids ferruginol and taxodione were found to be the most promising isolates, which were then further investigated at five different concentrations, and both diterpenoids exhibited high activity, particularly against BChE enzyme with IC50 values of 7.73 and 10.52 μM, respectively. Salvia chrysophylla and Salvia poculata extracts also exhibited moderate anticholinesterase activity.
Export Options
About this article
Cite this article as:
Topcu Gulactı, Kolak Ufuk, Ozturk Mehmet, Boga Mehmet, Damla Hatipoglu Seda, Bahadori Fatemeh, Culhaoglu Burcu and Dirmenci Tuncay, Investigation of Anticholinesterase Activity of a Series of Salvia Extracts and the Constituents of Salvia staminea, The Natural Products Journal 2013; 3 (1) . https://dx.doi.org/10.2174/2210315511303010003
DOI https://dx.doi.org/10.2174/2210315511303010003 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Erythropoietin Employs Cell Longevity Pathways of SIRT1 to Foster Endothelial Vascular Integrity During Oxidant Stress
Current Neurovascular Research Patent Selections
Recent Patents on Cardiovascular Drug Discovery Fas Ligand Gene Therapy for Vascular Intimal Hyperplasia
Current Gene Therapy Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy
Inflammation & Allergy - Drug Targets (Discontinued) Gene Therapy for the Prevention of Ischemia / Reperfusion Injury in Organ Transplantation
Current Gene Therapy Bisphenol A as a Factor in the Mosaic of Autoimmunity
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuropharmacology of Stress-Induced Mucosal Inflammation: Implications for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Current Molecular Medicine Cellular and Physiological Effects of Arginine
Mini-Reviews in Medicinal Chemistry Protective Role of Melatonin in Liver Damage
Current Pharmaceutical Design Novel Nanostructured Polymeric Carriers to Enable Drug Delivery for Cardiovascular Diseases
Current Pharmaceutical Design Systematic Investigation of Quercetin for Treating Cardiovascular Disease Based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications
Current Pharmaceutical Design microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Current Drug Targets Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?
Current Pharmaceutical Design The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa
Current Topics in Medicinal Chemistry Role of Free Radicals in Sepsis: Antioxidant Therapy
Current Pharmaceutical Design SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice
Current Alzheimer Research Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions
Current Medicinal Chemistry Modulation of Neutrophil Development and Homeostasis
Current Molecular Medicine Effects of Intravenous Apo A-I, HDLs and Apo A-I/Phospholipid Discs on Vascular Metabolism and Atherosclerosis in Animals and Humans
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents